Drug major Cipla posted a 25.5 per cent increase in its profit after tax at Rs.338.78 crore for the third quarter ended December 31, 2012, against Rs.269.91 crore in the corresponding period of the previous fiscal.
Gross revenues grew by 18 per cent to Rs.2,103 crore from Rs.1,783 crore and net sales to Rs.2,030.70 crore from Rs.1,711.47 crore. The operating margins have risen by 25.4 per cent to Rs.493 crore from Rs.393 crore.
Domestic revenues grew by 10.2 per cent to Rs.957 crore from Rs.869 crore, largely on account of growth in anti-asthma, anti-biotics and cardiovascular therapy segments.
Astrazeneca Pharma posted a net loss of Rs.17.69 crore for the third quarter ended December 31, 2012, against Rs.14.93 crore in the corresponding period of the previous fiscal. Net sales also declined to Rs.104.91 crore from Rs.153.48 crore, the company said in a statement. At the end of the previous financial year, the factory experienced interruptions to supply of certain products. In January 2013, it experienced a further interruption in production, which is under the process of remediation. “As a result, revenues and the financial results for the current quarter and nine months ended December 31, 2012, are lower compared to the prior year,” it added.
Apollo Tyres has reported a 84.21 per cent increase in its consolidated net profit at Rs.180.60 crore for the quarter ended December 31, 2012, against Rs.98.04 crore in the corresponding period in the previous year, mainly on account of robust sales in after-markets.
The consolidated net income, however, went down marginally to Rs.3,217.35 crore from Rs.3,228.24 crore.
The company’s European subsidiary Apollo Vredestein BV contributed Rs.816 crore to total income, while Rs.105 crore came as net profit.
Godrej Industries posted a consolidated net profit of Rs.179.44 crore for the third quarter ended December 31, 2012, driven by robust growth in its agri-business segment.
The copmany had posted a net profit of Rs.84.73 crore in the same period in the previous fiscal.
Total income stood at Rs.1,713.14 crore against Rs.1,453.79 crore in the year-ago period.
In view of the changes in the company’s shareholdings during the period in some of the subsidiaries, joint ventures and associates, the consolidated results for the period are not strictly comparable with those of the previous period, the company said.
Ballarpur Industries reported a 18.51 per cent decline in its consolidated net profit at Rs.15.40 crore in the second quarter ended December 31, 2012 against a net profit of Rs.18.90 crore in the corresponding period of previous fiscal.
The company follows a July-June fiscal year.
Revenues stood at Rs.1,186.80 crore against Rs.1,196 crore.
Keywords: corporate results